NHMRC Investigators and Programs
Investigators
2022 Investigators
Prof David Fairlie
University of Queensland
“Modulating protein-protein interactions in disease”
$3,927,015
Prof Trent Woodruff
University of Queensland
Developing new therapies targeting innate immune mediated inflammation in neurodegenerative disease
$3,372,570
Prof Kate Schroder
University of Queensland
Inflammasome inhibitors as new first-in-class anti-inflammatory therapies
$2,872,570
Prof Jason Roberts
University of Queensland
Translating precision antibiotic dosing into better outcomes for severe infections
$2,772,570
Prof Gabrielle Belz
University of Queensland
Harnessing immune cell programs to drive immune protection
$1,941,612
Dr Kirsty Short
University of Queensland
Pandemic-proofing our future
$1,370,120
2021 Investigators
Prof Mark Walker
University of Queensland
"Scarlet fever pandemic and reversing antibiotic resistance"
$3,414,215
Prof Don McManus
QIMR Berghofer Medical Research Institute
"A worm-free world: defeating parasitic helminths via global integrated control"
$2,714,215
Prof Peter Sly
University of Queensland
"Early life exposures and chronic disease: mechanisms and preventative strategies"
$2,714,215
Prof Matthew Sweet
University of Queensland
"Reprogramming innate immunity to combat inflammatory and infectious diseases"
$1,788,220
Prof Colleen Lau
University of Queensland
"Building Decision Support Systems to Combat Emerging Infectious Diseases and Neglected Tropical Diseases: A Precision Public Health Approach"
$1,562,250
Dr Adam Irwin
University of Queensland
"Overcoming the barriers to treatment of multi-drug resistant Gram-negative bloodstream infections in Australian children"
$447,603
2020 Investigators
Prof Andreas Suhrbier
QIMR Berghofer Medical Research Institute
"Developing interventions for chikungunya virus and Zika virus"
$2,548,640.00
Prof Ian Frazer
University of Queensland
"Pathogen promoters of squamous epithelial cancer"
$2,000,000.00
Prof Jennifer Stow
University of Queensland
"GTPase regulation of cellular pathways in inflammation and cancer"
$2,048,640.00
Prof David Paterson
University of Queensland
"Clinical Trials of Strategies of Treatment of Antibiotic Resistant Bacteria"
$1,624,320.00
Programs
Immunotherapy for infection and cancer; 2015-2019 $10,150,00
R. Thomas (UQ)
P. Hugenholtz (UQ AID)
G. Hill (QIMRB)
M. Degli-Esposti (UWA)
I. Frazer (UQ AID)
Proteins, glycans and host-pathogen interactions: targets for novel drugs and vaccines; 2015-2019 $8,795,785
J.C. Paton (University of Adelaide)
M.P. Jennings (Griffith University)
M. von Itzstein (Griffith University)
M.J. Walker (UQ AID)
B. Kobe (UQ AID)
Immunotherapy in cancer and virus infection; 2018-2022 $9,312,735
R. Khanna (QIMRB AID)
S.R. Burrows (QIMRB AID)
D.M. Thomas (Garvan Institute)
Tropical diseases: Translating discoveries into better health; 2018-2022 $19,803,660
J. McCarthy (QIMRB AID)
N. Anstey (CDU)
D. Doolan (JCU)
C. Engwerda (QIMRB AID)
M. Good (Griffith)
A. Loukas (JCU)
R. Price (MSHR)
D. McManus (QIMRB AID)
I. Toth (UQ AID
A pledge to AID goes directly into the research of issues that impact the lives of many people and their families.